Dergiler / International Journal of Chemistry and Technology / 2026 / Volume: 9 Issue: 1

Evaluation of Antioxidant, Antiproliferative and Anticholinesterase Activities of Iberis carnosa Willd

İmran Uysal(Osmaniye Korkut Ata Üniversitesi)0000-0003-0942-9658
Sayfa
—
Yayın Tarihi
2025-06-24
🏛️Bu makalenin bibliyografik verileri ve tam metin bağlantısı DergiPark üzerinden sağlanmıştır.
DergiPark Kaydı ↗
✨

Yapay Zeka Hızlı Bakış & Çıkarımlar

AI Insight
⚡ TL;DR(1 Cümlede Hızlı Çıkarım)

These findings suggest that I. carnosa possesses significant biological activities and warrants further investigation for potential therapeutic applications, particularly in neurodegenerative diseases and cancer.

📌 3 Maddede Bu Makale

🎯
Amaç & Hipotez:This study investigated the bioactivity of Iberis carnosa Willd, a plant known for its diverse natural compound.
📊
Temel Bulgular & Veri:Antioxidant capacity was quantified using Rel Assay kits, yielding a total antioxidant status (TAS) of 4.489±0.095 mmol/L, a total oxidant status (TOS) of 11.325±0.130 µmol/L, and an oxidative stress index (OSI) of 0.252±0.003.
💡
Sonuç & Katkı:These findings suggest that I. carnosa possesses significant biological activities and warrants further investigation for potential therapeutic applications, particularly in neurodegenerative diseases and cancer.
🔬Tür:Research Article
📍Kapsam:Genişletilmiş Akademik Örneklem
⚙️Değişkenler:Iberis carnosa · antioxidant activity · antiproliferative effect

Abstract

This study investigated the bioactivity of Iberis carnosa Willd, a plant known for its diverse natural compound. Utilizing Soxhlet extraction, an ethanol extract was prepared and subsequently analyzed for antioxidant, antiproliferative, and anticholinesterase activities. Antioxidant capacity was quantified using Rel Assay kits, yielding a total antioxidant status (TAS) of 4.489±0.095 mmol/L, a total oxidant status (TOS) of 11.325±0.130 µmol/L, and an oxidative stress index (OSI) of 0.252±0.003. Antiproliferative activity was assessed against the A549 lung cancer cell line, demonstrating a dose-dependent inhibition of cell growth. Anticholinesterase activity was evaluated by measuring acetylcholinesterase (AChE) and butyrylcholinesterase (BChE) inhibition, revealing values of 76.52±1.93 μg/mL for AChE and 119.84±1.50 μg/mL for BChE, respectively. These findings suggest that I. carnosa possesses significant biological activities and warrants further investigation for potential therapeutic applications, particularly in neurodegenerative diseases and cancer.

🔖

Bu Makaleye Atıf Yap

Uysal, İ. (2025). Evaluation of Antioxidant, Antiproliferative and Anticholinesterase Activities of Iberis carnosa Willd. International Journal of Chemistry and Technology, Volume: 9 Issue: 1. https://doi.org/10.32571/ijct.1668024

📄 Tam Metin PDF Okuyucu

📄

PDF görüntüleyici hazırlanıyor...

Kaynakça (35)

  1. Sevindik, M.; Yazar, M.; Polat, A. O.; Karatepe, H. K.; Uysal, İ.; Özdemir, B.; Uysal, N. Indian Journal of Natural Products and Resources, 2024,15, 473-490.
  2. Abdel-Aziz, S. M.; Aeron, A.; Kahil, T. A. Microbes in food and health, 2016, 97-116.
  3. Mohammed, F. S.; Uysal, I.; Sevindik, M. Prospects in Pharmaceutical Sciences, 2023, 21, 1-21.
  4. Sevindik, M.; Mohammed, F.S.; Uysal, I. Prospects in Pharmaceutical Sciences, 2023, 21, 38-48.
  5. Uysal, N.; Uysal, I.; Koçer, O.; Şabik, A. E.; Kaya, H.; Yaz, H. H. Eurasian Journal of Medical and Biological Sciences, 2025, 5, 40-57.
  6. Mohammed, F. S.; Sevindik, M.; Uysal, İ.; Çesko, C.; Koraqi, H. Measurement: Food, 2024, 100157.
  7. Sabik, A. E.; Sevindik, M.; Mohammed, F. S.; Dogan, M. Pharmaceutical Chemistry Journal, 2024, 58.
  8. Yazar, M.; Sevindik, M.; Polat, A. O.; Koçer, O.; Karatepe, H. K.; Uysal, İ. Prospects in Pharmaceutical Sciences, 2024, 22, 146-154.
  9. Ahmed, A.; Shuaib, M.; Shirsat, M. K.; Sharma, D. Indonesian Journal of Pharmaceutical and Clinical Research, 2023, 6, 13-24.
  10. Mamun, A. A.; Khan, M. S. S. Australian Herbal Insight, 2020, 3, 1-9.
  11. Oskay, D. Biological Diversity and Conservation, 2016, 9, 188-192.
  12. Çilden, E. Nordic Journal of Botany, 2022, e03671.
  13. Çilden, E.; Zare, G. Hacettepe Journal of Biology and Chemistry, 2019,47, 389-401.
  14. Erel O. Clinical biochemistry, 2004,37, 277-285.
  15. Erel O. Clinical biochemistry, 2005, 38, 1103-1111.
  16. Sevindik, M. Fresenius Environmental Bulletin, 2019, 28, 3713-3717.
  17. Ellman, G. L.; Courtney, K. D.; Andres Jr, V.; Featherstone, R. M. Biochemical pharmacology, 1961, 7, 88-95. 18. Bal, C.; Akgul, H.; Sevindik, M.; Akata, I.; Yumrutas, O. Fresenius Environmental Bulletin, 2017, 26, 6246-6252.
  18. Sevindik, M.; Akgul, H.; Dogan, M.; Akata, I.; Selamoglu, Z. Fresenius environmental Bulletin, 2018, 27, 1946-1952.
  19. Mishra, N.; Jiang, C.; Chen, L.; Paul, A.; Chatterjee, A.; Shen, G. Frontiers in Plant Science, 2023,14, 1110622.
  20. Vicidomini, C.; Palumbo, R.; Moccia, M.; Roviello, G. N. Journal of Xenobiotics, 2024, 14, 1541-1569.
  21. Hasanuzzaman, M.; Bhuyan, M. B.; Zulfiqar, F.; Raza, A.; Mohsin, S. M.; Mahmud, J. A.; Fotopoulos, V. Antioxidants, 2020, 9, 681.
  22. Schempp, H.; Totha, A.; Weiser, D.; Elstner, E. F. Arzneimittelforschung, 2003, 53, 568-577.
  23. Golkar, P.; Moattar, F. Natural Product Communications, 2019, 14, 1934578X19846355.
  24. Unal, O.; Eraslan, E. C.; Uysal, I.; Mohammed, F. S.; Sevindik, M.; Akgul, H. Fresenius Environmental Bulletin, 2022, 31, 7341-7346.
  25. Gürgen, A.; Sevindik, M.; Krupodorova, T.; Uysal, I.; Unal, O. BMC biotechnology, 2024, 24, 83.
  26. Sevindik, M.; Gürgen, A.; Krupodorova, T.; Uysal, İ.; Koçer, O. Scientific Reports, 2024, 14, 31403.
  27. Uysal, I.; Sevindik, M.; Dogan, M.; Mohammed, F. S.; Seğmenoğlu, M. S.; Pehlivan, M. Pharmaceutical Chemistry Journal, 2024, 58, 1289-1297.
  28. Gürgen, A.; Sevindik, M. Journal of Food Processing and Preservation, 2022, 46, e16949.
  29. Uysal, İ. International Journal of Chemistry and Technology, 2022, 6, 93-96.
  30. Santos, T. C. D.; Gomes, T. M.; Pinto, B. A. S.; Camara, A. L.; Paes, A. M. D. A. Frontiers in Pharmacology, 2018, 9, 1192.
  31. Gülçin, İ.; Gören, A. C.; Taslimi, P.; Alwasel, S. H.; Kılıc, O.; Bursal, E. Biocatalysis and agricultural biotechnology, 2020, 23, 101441.
  32. Murray, A. P.; Biscussi, B.; Cavallaro, V.; Donozo, M.; Rodriguez, S. A. Current Neuropharmacology, 2024, 22, 1621-1649.
  33. Jamal, Q. M. S.; Khan, M. I.; Alharbi, A. H.; Ahmad, V.; Yadav, B. S. Nutrients, 2023,15, 1579. 35. Sevindik, M.; Akgul, H.; Selamoglu, Z.; Braidy, N. Oxidative medicine and cellular longevity, 2020, 5620484.
  34. Alzahrani, A. R.; Hosny, N.; Mohamed, D. I.; Nahas, H. H. A.; Albogami, A.; Al-Hazani, T. M. I.; Saied, E. M. RSC advances, 2024, 14, 19400-19427.
  35. Bada, L.; Pereira, R. B.; Pereira, D. M.; Lores, M.; Celeiro, M.; Quezada, E.; Viña, D. Molecules, 2023, 28, 351.